Third, the patient had strong polyvalent atopic sensitization, and there is evidence supporting the efficacy of omalizumab in other IgE-meditated diseases such as chronic spontaneous urticaria, allergic rhinitis, nasal polyposis and food allergy, regardless of IgE level [8]. The gene discussed is IGHE; the disease is allergic rhinitis.